AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Pediatrix Medical Group, Inc.

$26.77 +$5.48 (+25.74%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$26.73
Day Range
$26.64$27.21
Year Range
$15.7$27.94
Market Cap
2.2B
AVG Volume
813.72K
Trailing/Forward PE
12.69/10.97
PEG ratio
3.24
Dividend Yield
-
Next Earnings Date
2026-11-02
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q2487.78M
26 Q1476.2M
25 Q4493.77M
25 Q3492.88M
25 Q2468.84M
25 Q1458.36M
24 Q4502.36M
24 Q3511.16M
24 Q2504.3M
24 Q1495.1M
Net Income (USD)
-200M-100M0100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q239.84M
26 Q129.57M
25 Q433.68M
25 Q371.71M
25 Q239.26M
25 Q120.74M
24 Q430.48M
24 Q319.44M
24 Q2-153.03M
24 Q14.04M
Operating Income (USD)
-200M-100M0100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q256.92M
26 Q146.58M
25 Q454.67M
25 Q368.05M
25 Q259.87M
25 Q132.1M
24 Q439.29M
24 Q333.83M
24 Q2-157.72M
24 Q115.89M
EBITDA (USD)
-200M-100M0100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q257.45M
26 Q153.23M
25 Q459.97M
25 Q396.39M
25 Q269.41M
25 Q142.58M
24 Q449.91M
24 Q341.62M
24 Q2-148.63M
24 Q128.73M
Cash Flows (USD)
-200M-100M0100M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2123.94M
26 Q1-135.75M
25 Q4108.81M
25 Q3131.95M
25 Q2132.65M
25 Q1-120.78M
24 Q4129.57M
24 Q385.55M
24 Q299.99M
24 Q1-130.56M
EPS (USD)
-2-10124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD EPS (USD) by quarter
PeriodEPS (USD)
26 Q20.49
26 Q10.36
25 Q40.4
25 Q30.84
25 Q20.45
25 Q10.24
24 Q40.35
24 Q30.23
24 Q2-1.84
24 Q10.05
Expenses (USD)
020M40M60M80MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q262.67M
26 Q166.51M
25 Q470.97M
25 Q366.13M
25 Q260.23M
25 Q161.92M
24 Q466.99M
24 Q364.41M
24 Q263.53M
24 Q165.53M
Cash & Debt (USD)
0200M400M600M800MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q2404.2M
26 Q1328.97M
25 Q4499.72M
25 Q3463.1M
25 Q2348.33M
25 Q1219.18M
24 Q4348.51M
24 Q3220.45M
24 Q2133.2M
24 Q1115.47M
Debt ratios
-40-200204024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD Debt ratios by quarter
PeriodDebt ratios
26 Q20.81
26 Q11.08
25 Q40.6
25 Q30.69
25 Q21.48
25 Q1-30.02
24 Q4-11.06
24 Q3-2.34
24 Q2-2.99
24 Q135.73
Margins
0%10%20%30%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD Margins by quarter
PeriodMargins
26 Q227.16%
26 Q123.72%
25 Q424.37%
25 Q328.48%
25 Q226.6%
25 Q122.39%
24 Q425.58%
24 Q322.85%
24 Q222.63%
24 Q119.16%
Return on Capital
-30%-20%-10%0%10%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD Return on Capital by quarter
PeriodReturn on Capital
26 Q24.52%
26 Q13.37%
25 Q43.89%
25 Q38.05%
25 Q24.71%
25 Q12.63%
24 Q43.98%
24 Q32.65%
24 Q2-21.66%
24 Q10.47%
Shares Outstanding
025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD Shares Outstanding by quarter
PeriodShares Outstanding
26 Q279.44M
26 Q183.08M
25 Q484.42M
25 Q385.37M
25 Q286.85M
25 Q185.81M
24 Q485.87M
24 Q383.89M
24 Q283.33M
24 Q182.86M
Book Value Per Share (USD)
05101524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q211.09
26 Q110.58
25 Q410.26
25 Q310.43
25 Q29.6
25 Q19.2
24 Q48.91
24 Q38.73
24 Q28.48
24 Q110.33
Total Assets (USD)
01B2B3B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MD Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q22.13B
26 Q12.07B
25 Q42.25B
25 Q32.2B
25 Q22.1B
25 Q11.99B
24 Q42.15B
24 Q32.08B
24 Q22B
24 Q12.17B
Employee Count
02K4K6K8K2016201720182019202020212022202320242025
MD Employee Count by quarter
PeriodEmployee Count
20252.26K
20242.15K
20232.9K
20222.8K
20212.73K
20203.6K
20195.17K
20187.62K
20177.67K
20167.4K
PE Ratio
68101214med 11.26Jul 23Oct 23Feb 24Oct 25Feb 26May 26Sep 26
MD PE Ratio by quarter
PeriodPE Ratio
Sep 2612.17
Sep 2612.28
Aug 2612.09
Aug 2612.07
Aug 2612.09
Aug 2612.31
Jul 2612.64
Jul 2612.52
Jul 2612.46
Jul 2612.53
Jul 2612.76
Jun 2611.77
Jun 2611.26
Jun 2611.59
Jun 2610.78
May 2610.27
May 2610.14
May 2610.72
May 2611.21
May 2611.61
Apr 2611.76
Apr 2611.78
Apr 2610.95
Apr 2610.81
Mar 2610.46
Mar 2610.05
Mar 269.98
Mar 2610.08
Feb 2610.13
Feb 269.61
Feb 2611.33
Feb 2611
Jan 2611.25
Jan 2611.34
Jan 2611.51
Jan 2611.76
Jan 2611.21
Dec 2511.51
Dec 2511.53
Dec 2511.84
Dec 2511.64
Nov 2512.68
Nov 2512.16
Nov 2512.19
Nov 2511.54
Oct 2513.41
Oct 2513.91
Oct 2513
Oct 2512.48
Oct 2513.83
Sep 2512.88
Sep 2512.86
Sep 2513.15
Sep 2513.49
Aug 2513.6
Aug 2513.44
Aug 2512.67
Aug 2511.32
Feb 248.2
Feb 248
Feb 248.22
Jan 248.7
Jan 248.22
Jan 248.49
Jan 248.54
Dec 238.21
Dec 238.42
Dec 237.97
Dec 238.16
Dec 237.74
Nov 237.8
Nov 238.03
Nov 238.13
Nov 238.74
Oct 239.07
Oct 2310.11
Oct 239.43
Oct 2310.32
Sep 2310.18
Sep 239.92
Sep 2310.2
Sep 2310.2
Sep 2311.19
Aug 2311.28
Aug 2311.97
Aug 2311.82
Aug 2311.72
Jul 2310.93
Jul 2311.37
Jul 2311.11
Jul 2310.81
Jun 2311.44
Jun 2310.98
Jun 2311.17
Jun 2311.52
Jun 2311.26
May 2310.76
May 2310.99
May 2311.15
May 2311.02
Free Cash Flow Yield
5%10%15%20%med 14.58%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MD Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2610.77%
Sep 2610.66%
Aug 2610.83%
Aug 2610.85%
Aug 2610.83%
Aug 2610.64%
Jul 2610.79%
Jul 2610.89%
Jul 2610.95%
Jul 2610.89%
Jul 2610.69%
Jun 2611.59%
Jun 2612.12%
Jun 2611.77%
Jun 2612.65%
May 2613.28%
May 2613.46%
May 2612.72%
May 2612.17%
May 2613.15%
Apr 2612.99%
Apr 2612.97%
Apr 2613.95%
Apr 2614.13%
Mar 2614.6%
Mar 2615.19%
Mar 2615.3%
Mar 2615.15%
Feb 2615.08%
Feb 2615.9%
Feb 2614.88%
Feb 2615.33%
Jan 2614.98%
Jan 2614.87%
Jan 2614.65%
Jan 2614.34%
Jan 2615.04%
Dec 2514.64%
Dec 2514.62%
Dec 2514.23%
Dec 2514.48%
Nov 2513.29%
Nov 2513.86%
Nov 2513.83%
Nov 2514.6%
Oct 2515.4%
Oct 2514.85%
Oct 2515.89%
Oct 2516.54%
Oct 2514.93%
Sep 2516.03%
Sep 2516.06%
Sep 2515.71%
Sep 2515.31%
Aug 2515.19%
Aug 2515.36%
Aug 2516.29%
Aug 2518.24%
Aug 2518.9%
Jul 2518.02%
Jul 2518.02%
Jul 2517.26%
Jul 2516.43%
Jun 2516.14%
Jun 2517.13%
Jun 2516.18%
Jun 2516.07%
May 2516%
May 2516.7%
May 2515.17%
May 2515.59%
May 2516.61%
Apr 2517.55%
Apr 2516.77%
Apr 2516.11%
Apr 2515.91%
Mar 2515.18%
Mar 2515.13%
Mar 2515.67%
Mar 2514.68%
Feb 2514.55%
Feb 2513.77%
Feb 259.77%
Feb 2510.07%
Jan 259.82%
Jan 259.59%
Jan 259.92%
Jan 2511.04%
Jan 2510.45%
Dec 2410.18%
Dec 249.74%
Dec 249.76%
Dec 249.28%
Nov 249.18%
Nov 249.18%
Nov 249.7%
Nov 248.71%
Nov 249.03%
Oct 249.71%
Oct 249.44%
Price to Sales
0.40.60.811.2med 0.76Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MD Price to Sales by quarter
PeriodPrice to Sales
Sep 261.09
Sep 261.1
Aug 261.08
Aug 261.08
Aug 261.08
Aug 261.1
Jul 261.14
Jul 261.13
Jul 261.12
Jul 261.13
Jul 261.15
Jun 261.06
Jun 261.02
Jun 261.05
Jun 260.97
May 260.93
May 260.91
May 260.97
May 261.01
May 261
Apr 261.02
Apr 261.02
Apr 260.95
Apr 260.93
Mar 260.9
Mar 260.87
Mar 260.86
Mar 260.87
Feb 260.88
Feb 260.83
Feb 260.96
Feb 260.93
Jan 260.95
Jan 260.96
Jan 260.97
Jan 260.99
Jan 260.95
Dec 250.97
Dec 250.97
Dec 251
Dec 250.98
Nov 251.07
Nov 251.03
Nov 251.03
Nov 250.97
Oct 250.76
Oct 250.79
Oct 250.74
Oct 250.71
Oct 250.78
Sep 250.73
Sep 250.73
Sep 250.74
Sep 250.76
Aug 250.77
Aug 250.76
Aug 250.72
Aug 250.64
Aug 250.52
Jul 250.55
Jul 250.55
Jul 250.57
Jul 250.6
Jun 250.61
Jun 250.57
Jun 250.61
Jun 250.61
May 250.61
May 250.59
May 250.65
May 250.63
May 250.55
Apr 250.52
Apr 250.55
Apr 250.57
Apr 250.58
Mar 250.6
Mar 250.61
Mar 250.59
Mar 250.62
Feb 250.63
Feb 250.67
Feb 250.59
Feb 250.57
Jan 250.58
Jan 250.6
Jan 250.58
Jan 250.52
Jan 250.55
Dec 240.56
Dec 240.59
Dec 240.59
Dec 240.62
Nov 240.63
Nov 240.63
Nov 240.59
Nov 240.66
Nov 240.64
Oct 240.52
Oct 240.53
EV/EBITDA
020406080med 8.32Dec 23Apr 24Jul 24Oct 25Feb 26May 26Sep 26
MD EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 268.77
Sep 268.85
Aug 268.72
Aug 268.71
Aug 268.72
Aug 268.86
Jul 268.97
Jul 268.9
Jul 268.86
Jul 268.9
Jul 269.05
Jun 268.43
Jun 268.11
Jun 268.31
Jun 267.81
May 267.49
May 267.41
May 267.77
May 268.08
May 267.76
Apr 267.85
Apr 267.86
Apr 267.35
Apr 267.26
Mar 267.05
Mar 266.8
Mar 266.75
Mar 266.81
Feb 266.84
Feb 266.52
Feb 267.81
Feb 267.6
Jan 267.76
Jan 267.81
Jan 267.92
Jan 268.08
Jan 267.73
Dec 257.92
Dec 257.94
Dec 258.13
Dec 258
Nov 258.66
Nov 258.33
Nov 258.35
Nov 257.94
Oct 258.72
Oct 258.99
Oct 258.5
Oct 258.22
Oct 258.95
Sep 258.44
Sep 258.42
Sep 258.58
Sep 258.77
Aug 258.82
Aug 258.74
Aug 258.33
Aug 257.6
Aug 2471.39
Jul 2472.51
Jul 2469.29
Jul 2468.76
Jul 2466.13
Jun 2469.43
Jun 2471.44
Jun 2468.05
Jun 2467.51
May 2468.36
May 2469.03
May 2470.28
May 2472.42
May 2443.76
Apr 2442.94
Apr 2442.91
Apr 2443.5
Apr 2443.9
Mar 2445.73
Mar 2443.73
Mar 2444.18
Mar 2442.91
Mar 2442.18
Feb 2442.24
Feb 246.87
Feb 246.77
Feb 246.87
Jan 247.1
Jan 246.88
Jan 247
Jan 247.03
Dec 236.87
Dec 236.97
Dec 236.76
Dec 236.85
Dec 236.65
Nov 236.68
Nov 236.79
Nov 236.83
Nov 237.12
Oct 237.74
Oct 238.27
Price/Operating Cashflow
46810med 6.45Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MD Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 268.6
Sep 268.69
Aug 268.55
Aug 268.54
Aug 268.55
Aug 268.7
Jul 268.5
Jul 268.42
Jul 268.38
Jul 268.42
Jul 268.58
Jun 267.91
Jun 267.57
Jun 267.79
Jun 267.25
May 266.91
May 266.82
May 267.21
May 267.54
May 267.08
Apr 267.17
Apr 267.18
Apr 266.68
Apr 266.6
Mar 266.38
Mar 266.13
Mar 266.09
Mar 266.15
Feb 266.18
Feb 265.86
Feb 266.33
Feb 266.15
Jan 266.29
Jan 266.34
Jan 266.43
Jan 266.58
Jan 266.27
Dec 256.44
Dec 256.45
Dec 256.62
Dec 256.51
Nov 257.09
Nov 256.8
Nov 256.81
Nov 256.46
Oct 256.03
Oct 256.25
Oct 255.84
Oct 255.61
Oct 256.22
Sep 255.79
Sep 255.78
Sep 255.91
Sep 256.06
Aug 256.11
Aug 256.04
Aug 255.7
Aug 255.09
Aug 254.8
Jul 255.03
Jul 255.03
Jul 255.25
Jul 255.52
Jun 255.62
Jun 255.29
Jun 255.6
Jun 255.64
May 255.66
May 255.43
May 255.98
May 255.82
May 255.38
Apr 255.09
Apr 255.33
Apr 255.55
Apr 255.62
Mar 255.89
Mar 255.91
Mar 255.7
Mar 256.09
Feb 256.14
Feb 256.49
Feb 258.25
Feb 258.01
Jan 258.21
Jan 258.41
Jan 258.13
Jan 257.31
Jan 257.72
Dec 247.92
Dec 248.28
Dec 248.26
Dec 248.69
Nov 248.79
Nov 248.79
Nov 248.31
Nov 249.26
Nov 248.93
Oct 247.9
Oct 248.12
Price to Book
11.522.53med 1.78Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MD Price to Book by quarter
PeriodPrice to Book
Sep 262.41
Sep 262.44
Aug 262.4
Aug 262.4
Aug 262.4
Aug 262.44
Jul 262.51
Jul 262.48
Jul 262.47
Jul 262.48
Jul 262.53
Jun 262.33
Jun 262.23
Jun 262.3
Jun 262.14
May 262.04
May 262.01
May 262.13
May 262.22
May 262.22
Apr 262.25
Apr 262.25
Apr 262.09
Apr 262.06
Mar 262
Mar 261.92
Mar 261.91
Mar 261.93
Feb 261.94
Feb 261.83
Feb 262.06
Feb 262
Jan 262.05
Jan 262.06
Jan 262.1
Jan 262.14
Jan 262.04
Dec 252.1
Dec 252.1
Dec 252.16
Dec 252.12
Nov 252.31
Nov 252.21
Nov 252.22
Nov 252.1
Oct 251.77
Oct 251.83
Oct 251.71
Oct 251.65
Oct 251.82
Sep 251.7
Sep 251.69
Sep 251.73
Sep 251.78
Aug 251.79
Aug 251.77
Aug 251.67
Aug 251.49
Aug 251.3
Jul 251.37
Jul 251.37
Jul 251.43
Jul 251.5
Jun 251.53
Jun 251.44
Jun 251.52
Jun 251.53
May 251.54
May 251.47
May 251.62
May 251.58
May 251.45
Apr 251.38
Apr 251.44
Apr 251.5
Apr 251.52
Mar 251.59
Mar 251.6
Mar 251.54
Mar 251.64
Feb 251.66
Feb 251.75
Feb 251.61
Feb 251.56
Jan 251.6
Jan 251.64
Jan 251.59
Jan 251.42
Jan 251.5
Dec 241.54
Dec 241.61
Dec 241.61
Dec 241.7
Nov 241.71
Nov 241.71
Nov 241.62
Nov 241.8
Nov 241.74
Oct 241.46
Oct 241.51
Pediatrix Medical Group, Inc.
MD
Stockpicker

Video analysis: MD

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: MD

Sinopharm Group (OTCMKTS:SHTDY) and Pediatrix Medical Group (NYSE:MD) Financial Survey

defenseworld.net · 4 Sep 2026

Sinopharm Group (OTCMKTS:SHTDY) and Pediatrix Medical Group (NYSE:MD) Financial Survey

Sinopharm Group (OTCMKTS:SHTDY - Get Free Report) and Pediatrix Medical Group (NYSE: MD - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability. Analyst Recommendations This is a breakdown of

Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?

zacks.com · 3 Sep 2026

Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?

Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?

Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?

zacks.com · 1 Sep 2026

Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

TEZSPIRE demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints

gurufocus.com · 27 Aug 2026

TEZSPIRE demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints

Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis (EoE) showed that AstraZeneca and Amgen's TEZSPIREÂ (te

Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock

zacks.com · 20 Aug 2026

Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

zacks.com · 13 Aug 2026

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its growth prospects.

Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock

zacks.com · 12 Aug 2026

Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Pediatrix Medical Tops Q2 Earnings on Better Cash Collections

zacks.com · 6 Aug 2026

Pediatrix Medical Tops Q2 Earnings on Better Cash Collections

MD posts a Q2 earnings beat as stronger cash collections and a favorable payor mix lift results despite lower volumes.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.